Logo
Richard Parker @pharmacontractor
10 days ago
Pharmaceutical Contract Manufacturing Services: What They Are and Why They Matter
07:15 AM - Jun 26, 2025 (UTC)
Richard Parker @pharmacontractor
1 month ago
Why More Pharma Companies Are Turning to Contract Manufacturing in 2025
09:55 AM - May 23, 2025 (UTC)
Richard Parker @pharmacontractor
2 months ago
Accelerate Development with Lannett CDMO
- Streamlined development of oral solid dose formulations
- Extensive expertise and high-volume manufacturing
- Commitment to quality and regulatory compliance

Our track record speaks volumes
- 17 approved product applications since 2019
- 96% average product yield rate
- Zero critical FDA Form 483 observations

Learn More About Partnering with Lannett.

https://www.lannettcdmo.co...
10:39 AM - May 22, 2025 (UTC)
Richard Parker @pharmacontractor
2 months ago
Why Tablet Contract Manufacturers Are Key to Scalable Pharmaceutical Growth
https://pharmacontractor.b...
07:58 AM - May 21, 2025 (UTC)
Richard Parker @pharmacontractor
2 months ago
Growth Through Pharmaceutical Contract Manufacturing Services: The CDMO Advantage
https://pharmacontractor.b...
10:10 AM - May 07, 2025 (UTC)
Richard Parker @pharmacontractor
2 months ago
Why More Pharma Companies Are Turning to Contract Tablet Manufacturers
https://pharmacontractor.e...
09:33 AM - May 06, 2025 (UTC)
Richard Parker @pharmacontractor
2 months ago
Our manufacturing capacity grows with your needs. When you're ready to scale up, we deliver consistent quality at higher volumes.
https://www.lannettcdmo.co...
03:25 AM - Apr 24, 2025 (UTC)
Richard Parker @pharmacontractor
5 months ago
Pharmaceutical Contract Manufacturing: A Growing Industry
https://pharmacontractor.b...
06:53 AM - Feb 20, 2025 (UTC)
Richard Parker @pharmacontractor
5 months ago
The Rise of Biologics and Biosimilars: What It Means for Patients and Pharma
https://pharmaceuticalcont...
10:53 AM - Feb 06, 2025 (UTC)
Richard Parker @pharmacontractor
5 months ago
Did you know? The total GLP-1 market is projected to reach a potential $200 billion by 2031.
As such, oral solid dose (OSD) formulations are poised to gain significant traction.
This shift demands manufacturing partners with proven expertise in:

💊Specialized potent compound handling

⏳ Modified release technology

🎯 Precise quality control systems

📈 Continuity of supply

https://www.lannettcdmo.co...
09:48 AM - Feb 04, 2025 (UTC)